ATIM-21. INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH HIGH GRADE GLIOMA RESULTS IN QUANTIFIABLE EXPRESSION OF CYTOSINE DEAMINASE IN TUMOR TISSUE

Tobias Walbert,Daniela A. Bota,Michael A. Vogelbaum,Steven N. Kalkanis,Linda M. Liau,Tom Mikkelsen,Harry E. Gruber,Jolene Shorr,Maria Rodriguez-Aquirre,Derek Ostertag,Leah Mitchell,Douglas J. Jolly,Timothy F. Cloughesy

ATIM-21. INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH HIGH GRADE GLIOMA RESULTS IN QUANTIFIABLE EXPRESSION OF CYTOSINE DEAMINASE IN TUMOR TISSUE

2017

Tobias Walbert
Daniela A. Bota
Michael A. Vogelbaum
Steven N. Kalkanis
Linda M. Liau
Tom Mikkelsen
Harry E. Gruber
Jolene Shorr
Maria Rodriguez-Aquirre
Derek Ostertag
Leah Mitchell
Douglas J. Jolly
Timothy F. Cloughesy

Author(s): Walbert, Tobias; Bota, Daniela; Vogelbaum, Michael; Kalkanis, Steven; Liau, Linda; Mikkelsen, Tom; Gruber, Harry; Shorr, Jolene; Rodriguez-Aquirre, Maria; Ostertag, Derek; Mitchell, Leah; Jolly, Douglas; Cloughesy, Timothy

Keywords:

Pathology
Immunology
High-Grade Glioma
Medicine
Cytosine deaminase
in patient
tumor tissue
Text mining

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations